{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7477,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-862c-74eb-a1c6-035540787a6a",
      "docSlug": "0c16cbe7f9f11d0d4dde4442bc0ea51b",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a horizontal timeline format to map product milestones against calendar years.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-862c-74eb-a1c6-035540787a6a/17",
      "deckHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a",
      "deckAnchorHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-862c-74eb-a1c6-035540787a6a",
      "docSlug": "0c16cbe7f9f11d0d4dde4442bc0ea51b",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-862c-74eb-a1c6-035540787a6a/18",
      "deckHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a",
      "deckAnchorHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-862c-74eb-a1c6-035540787a6a",
      "docSlug": "0c16cbe7f9f11d0d4dde4442bc0ea51b",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "team_bio",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-862c-74eb-a1c6-035540787a6a/19",
      "deckHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a",
      "deckAnchorHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 19,
          "beatId": "2d505f6d-74d8-451e-ae4d-1226e5a58880",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "The leadership team and advisors are presented on pages 19-20",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-862c-74eb-a1c6-035540787a6a",
      "docSlug": "0c16cbe7f9f11d0d4dde4442bc0ea51b",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide uses a grid layout to present 10 advisors, each with a headshot, name, role, and company logo.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-862c-74eb-a1c6-035540787a6a/20",
      "deckHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a",
      "deckAnchorHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 19,
          "beatId": "2d505f6d-74d8-451e-ae4d-1226e5a58880",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "The leadership team and advisors are presented on pages 19-20",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-862c-74eb-a1c6-035540787a6a",
      "docSlug": "0c16cbe7f9f11d0d4dde4442bc0ea51b",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a DNA helix as a creative timeline background, reflecting the company's focus on molecular diagnostics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-862c-74eb-a1c6-035540787a6a/21",
      "deckHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a",
      "deckAnchorHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-862c-74eb-a1c6-035540787a6a",
      "docSlug": "0c16cbe7f9f11d0d4dde4442bc0ea51b",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes income statement metrics, balance sheet data, and equity structure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-862c-74eb-a1c6-035540787a6a/22",
      "deckHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a",
      "deckAnchorHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-862c-74eb-a1c6-035540787a6a",
      "docSlug": "0c16cbe7f9f11d0d4dde4442bc0ea51b",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a grid-like layout to present six key value propositions surrounding a central product image.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-862c-74eb-a1c6-035540787a6a/23",
      "deckHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a",
      "deckAnchorHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 23,
          "beatId": "0b99a22a-e5c5-4f80-87c4-3c78596c4dd6",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Investment Ask",
          "beatSlug": "sequoia-pitch-the-ask",
          "evidence": "The investment highlights and thank you slide are presented on pages 23-24",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-862c-74eb-a1c6-035540787a6a",
      "docSlug": "0c16cbe7f9f11d0d4dde4442bc0ea51b",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "closing_ask",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-862c-74eb-a1c6-035540787a6a/24",
      "deckHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a",
      "deckAnchorHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 23,
          "beatId": "0b99a22a-e5c5-4f80-87c4-3c78596c4dd6",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Investment Ask",
          "beatSlug": "sequoia-pitch-the-ask",
          "evidence": "The investment highlights and thank you slide are presented on pages 23-24",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "Includes company logo, name, ticker symbol, and date.",
      "imagePath": "https://imgproxy.kitesheet.com/o8ib4hPsRE4T6-yOiXVBDvrBEvAPwJD6wL1RXLST_lU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYTIzNzg0NDYyYTEzMTA5M2NiMTE4MzEzZjcwNTk3YS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/1",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/sveHEyIiT2HSUVminANZ2UPJQjXyjjdvD9ayWUjIYsY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYTIzNzg0NDYyYTEzMTA5M2NiMTE4MzEzZjcwNTk3YS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/Cel3Ge-icw_Yg1PJRrig4HbVRDs7glnkR_ADK44xuZY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYTIzNzg0NDYyYTEzMTA5M2NiMTE4MzEzZjcwNTk3YS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/xWMJdFqCC1cqqoBYGZTGVBl9mElMc5foYNGLtVJEL3U/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYTIzNzg0NDYyYTEzMTA5M2NiMTE4MzEzZjcwNTk3YS9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/2",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "team_bio",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/3",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 3,
          "beatId": "12c1a744-a564-443d-af1b-dbe8a50ca0cb",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "Slide 3 highlights the strong leadership team",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/4",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 4,
          "beatId": "dbe82cfe-75f2-4785-9d67-d732f6043b6b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 4-5 discuss the target market and pipeline",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a standard pharmaceutical pipeline table format.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/5",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 4,
          "beatId": "dbe82cfe-75f2-4785-9d67-d732f6043b6b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 4-5 discuss the target market and pipeline",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/6",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/7",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 7,
          "beatId": "5ab81c27-84ad-4636-b15d-fb51c59b7f9b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-11 detail the solution, including DA-1241 and its effects",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The table highlights clinical status, mechanism of action, efficacy, safety, and strategic differentiation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/8",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-8",
      "loopMatches": [
        {
          "to": 11,
          "from": 8,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "12d85908-f74a-4938-912e-444c9b3e39a3",
          "evidence": "Slides 8-11 discuss DA-1241's competitive differentiation and effects",
          "position": 0,
          "objective": "What sets DA-1241 apart from existing treatments?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.6,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 7,
          "beatId": "5ab81c27-84ad-4636-b15d-fb51c59b7f9b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-11 detail the solution, including DA-1241 and its effects",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a biological process flow to explain the mechanism of action.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/9",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-9",
      "loopMatches": [
        {
          "to": 11,
          "from": 8,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "12d85908-f74a-4938-912e-444c9b3e39a3",
          "evidence": "Slides 8-11 discuss DA-1241's competitive differentiation and effects",
          "position": 0,
          "objective": "What sets DA-1241 apart from existing treatments?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.6,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 7,
          "beatId": "5ab81c27-84ad-4636-b15d-fb51c59b7f9b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-11 detail the solution, including DA-1241 and its effects",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes two heatmaps showing gene expression changes and a biological pathway diagram for GLP1 receptor activation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/10",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-10",
      "loopMatches": [
        {
          "to": 11,
          "from": 8,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "12d85908-f74a-4938-912e-444c9b3e39a3",
          "evidence": "Slides 8-11 discuss DA-1241's competitive differentiation and effects",
          "position": 0,
          "objective": "What sets DA-1241 apart from existing treatments?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.6,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 7,
          "beatId": "5ab81c27-84ad-4636-b15d-fb51c59b7f9b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-11 detail the solution, including DA-1241 and its effects",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "product_demo",
      "function": "analyze_data",
      "notes": "Includes study references and definitions for GPR119, MASH, GLP-1, and drug dosages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/11",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-11",
      "loopMatches": [
        {
          "to": 11,
          "from": 8,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "12d85908-f74a-4938-912e-444c9b3e39a3",
          "evidence": "Slides 8-11 discuss DA-1241's competitive differentiation and effects",
          "position": 0,
          "objective": "What sets DA-1241 apart from existing treatments?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.6,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 7,
          "beatId": "5ab81c27-84ad-4636-b15d-fb51c59b7f9b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-11 detail the solution, including DA-1241 and its effects",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide presents 11 distinct bar charts summarizing a study on drug efficacy in a mouse model of MASH (Metabolic dysfunction-associated steatohepatitis).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/12",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Notes at bottom define FPFV and LPO.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/13",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 13,
          "beatId": "0b194b23-dcf9-4757-99ec-a26b7f11f2c1",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Slides 13-20 provide information on DA-1241 and DA-1726, including clinical trials and comparisons",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "unfair_advantage",
      "function": "present_solution",
      "notes": "The slide uses a hub-and-spoke diagram to illustrate the multi-faceted mechanism of action of the drug target.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/14",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 13,
          "beatId": "0b194b23-dcf9-4757-99ec-a26b7f11f2c1",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Slides 13-20 provide information on DA-1241 and DA-1726, including clinical trials and comparisons",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/15",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 13,
          "beatId": "0b194b23-dcf9-4757-99ec-a26b7f11f2c1",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Slides 13-20 provide information on DA-1241 and DA-1726, including clinical trials and comparisons",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The table highlights DA-1726's dual agonist mechanism and potential for better tolerability compared to market leaders.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/16",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 13,
          "beatId": "0b194b23-dcf9-4757-99ec-a26b7f11f2c1",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Slides 13-20 provide information on DA-1241 and DA-1726, including clinical trials and comparisons",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a hub-and-spoke diagram to illustrate the systemic effects of oxyntomodulin.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/17",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 13,
          "beatId": "0b194b23-dcf9-4757-99ec-a26b7f11f2c1",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Slides 13-20 provide information on DA-1241 and DA-1726, including clinical trials and comparisons",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide uses three charts: a bar chart for food intake and two line charts for body weight loss (BWL) in different mouse models.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/18",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 13,
          "beatId": "0b194b23-dcf9-4757-99ec-a26b7f11f2c1",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Slides 13-20 provide information on DA-1241 and DA-1726, including clinical trials and comparisons",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide highlights that DA-1726 achieves weight loss through mechanisms other than just food reduction, as evidenced by higher food intake compared to Tirzepatide.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/19",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 13,
          "beatId": "0b194b23-dcf9-4757-99ec-a26b7f11f2c1",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Slides 13-20 provide information on DA-1241 and DA-1726, including clinical trials and comparisons",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "appendix_methodology",
      "function": "analyze_data",
      "notes": "Includes study design, population, and location details.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/20",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 13,
          "beatId": "0b194b23-dcf9-4757-99ec-a26b7f11f2c1",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "Slides 13-20 provide information on DA-1241 and DA-1726, including clinical trials and comparisons",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/21",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 22,
          "from": 21,
          "beatId": "cc3c5e8b-cf56-4d3b-9b42-acefa20a440d",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Financials",
          "beatSlug": "sequoia-pitch-financials",
          "evidence": "Slides 21-22 present financials and capitalization information",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "WAEP stands for Weighted Average Exercise Price.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/22",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 22,
          "from": 21,
          "beatId": "cc3c5e8b-cf56-4d3b-9b42-acefa20a440d",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Financials",
          "beatSlug": "sequoia-pitch-financials",
          "evidence": "Slides 21-22 present financials and capitalization information",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}